Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Feb 7, 2014 sanofi Beneficial Owner (10% or more) Buy 21,986 284.49 - 289.98
Mar 3, 2014 sanofi Beneficial Owner (10% or more) Buy 251,594 328.00 - 339.94
Mar 6, 2014 sanofi Beneficial Owner (10% or more) Buy 80,404 338.64 - 339.82
Feb 15, 2008 baker charles a Director Automatic Sell 10,000 18.67 - 19.06
Feb 15, 2008 baker charles a Director Option Execute 10,000 7.91
Feb 20, 2009 baker charles a Director Automatic Sell 10,000 18.16
Feb 20, 2009 baker charles a Director Option Execute 10,000 7.66
Jun 2, 2010 baker charles a Director Option Execute 5,000 25.43
Jul 1, 2011 baker charles a Director Automatic Sell 11,000 55.94 - 57.40
Mar 24, 2014 baker charles a Director Option Execute 15,000 23.84
Jun 10, 2013 baker charles a Director Automatic Sell 15,000 250.06 - 257.99
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Sep 30, 2013 baker charles a Director Option Execute 15,000 19.69
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 5, 2012 baker charles a Director Option Execute 1,286 15.01
Sep 6, 2012 baker charles a Director Automatic Sell 13,714 150.00
Sep 6, 2012 baker charles a Director Option Execute 13,714 15.01
Showing 41-60 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)